Advanced Filter

Filter by Group

Filter by Market Availability

Clear
Displaying drugs 8126 - 8150 of 9261 in total

UK-396,082

UK-396,082 has been used in trials studying the basic science of Safety, Phase 1, Toleration, Multiple Dose, and Pharmacokinetic.
Investigational

Paquinimod

Paquinimod is developed for the treatment of SLE (Systemic Lupus Erythematosus), which is an autoimmune disease. The disease affects mainly women of fertile age and progresses in flares with relatively symptom free periods in between. Current treatments of SLE are NSAID (nonsteroidal anti-inflammatory drugs), corticosteroids, antimalarians or cytotoxic drugs like...
Investigational

Poldine

Experimental

Tidiacic arginine

Experimental

Dihydrofolic Acid

Experimental

Mdl 101,146

Experimental

Cytidine-5'-Monophosphate-5-N-Acetylneuraminic Acid

A nucleoside monophosphate sugar which donates N-acetylneuraminic acid to the terminal sugar of a ganglioside or glycoprotein. [PubChem]
Experimental

GE-2270A

Experimental

C-1027 Aromatized chromophore

Experimental

Apstatin

Experimental

GW-559090

Investigational

METHYL N-[(2S,3R)-3-AMINO-2-HYDROXY-3-(4-METHYLPHENYL)PROPANOYL]-D-ALANYL-D-LEUCINATE

Experimental

Modufolin

Modufolin is under investigation for the treatment of Osteosarcoma.
Investigational

Propenidazole

Experimental

Daxalipram

Experimental

S-oxy-L-cysteine

Experimental

Tetrastearoyl cardiolipin

Experimental

12-Hydroxydodecanoic Acid

Experimental

3-Carboxy-N,N,N-Trimethyl-2-(Octanoyloxy)Propan-1-Aminium

Experimental

4-Methyl-Pyrroline-5-Carboxylic Acid

Experimental

Thiocitrulline

Experimental

3,3-Dichloro-2-Phosphonomethyl-Acrylic Acid

Experimental

Caprospinol

Caprospinol (SP-233) is the first drug ever to demonstrate the correlation of clearing beta-amyloid from the brain. It also improves the brain histopathology and recovers memory function.
Investigational

ENMD-1198

Investigational

ginkgolide-C

Nutraceutical
Displaying drugs 8126 - 8150 of 9261 in total